CompuMed, Inc.
CompuMed, Inc. develops and markets products and services that combine advanced imaging with medical informatics. Its focus is on analysis and remote monitoring for patients with cardiovascular and musculoskeletal diseases. The Company has specialized expertise and intellectual property in telemonitoring imaging and analysis designed to improve healthcare provider workflow and patient care while reducing costs. CompuMed's core products, the OsteoCareTM, OsteoGram® and CardioGramTM, are cleared by the FDA and reimbursable by Medicare. CompuMed OsteoCareTM system is a unique x-ray densitometer for the assessment of bone density in the distal part of the forearm utilizing DXA technology.
The OsteoGram® is a non-invasive diagnostic system that has been proven by many clinical studies to provide effective and accurate bone density measurement for screening osteoporosis and assessing hip fracture risk. The OsteoGram has significant cost advantages over other technologies in the marketplace. The CardioGramTM system is one of the first telecommunication networks designed to remotely interpret electrocardiograms and is used by private practice, as well as government and corporate healthcare providers nationwide. The CardioGram delivers online electrocardiogram interpretations within minutes of receipt and has the additional capability of automatically providing an over-read (i.e., follow-up review) by a cardiologist. CompuMed is headquartered in Los Angeles and distributes its products worldwide both directly and through OEM partners.
Contact Details
Office Address
CompuMed, Inc.
5777 W. Century Blvd., Suite 360
Los Angeles, California, USA 90045
Phone: +310-258-5000
Fax: +310-645-5880
Executives
Interim Chief Exec. Officer
Mr. Maurizio Vecchione
Principal Financial Officer
Ms. Phuong Dang
Chief Technology Officer
Ms. Xiaoli Bi